Brandywine Global Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Brandywine Global Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-27	Closed	-$1K	–	911
2019 Q1	$1K	Sell	27 -834,940	-100%	-$24.1M	﹤0.01%	842
2018 Q4	$16.3M	Buy	834,967 +87,999	+12%	+$1.81M	0.12%	156
2018 Q3	$19.9M	Sell	746,968 -6,298	-0.8%	-$206K	0.12%	144
2018 Q2	$28.5M	Sell	753,266 -8,024	-1%	-$307K	0.18%	122
2018 Q1	$24.9M	Buy	+761,290	New	+$33.4M	0.16%	129

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Brandywine Global Investment Management's PTLA Position: Q2 2019 in Review

Brandywine Global Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2019, closing a stake of 27 shares — an estimated $1K sold.

Brandywine Global Investment Management first reported a position in PTLA in Q1 2018 and held it in 5 quarters. The position peaked at $28.5M in Q2 2018. 202 funds tracked by Wall St. Rank hold PTLA as of Q2 2019.

Brandywine Global Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Brandywine Global Investment Management sold 27 Portola Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1K.
Brandywine Global Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2018 and held it in 5 quarters.
Brandywine Global Investment Management's Portola Pharmaceuticals, Inc. position peaked at $28.5M in Q2 2018.
202 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2019.

Based on Brandywine Global Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.